PING-ING LEEPO-REN HSUEH2020-03-272020-03-2720201684-1182https://scholars.lib.ntu.edu.tw/handle/123456789/479655[SDGs]SDG3arbidol; lamivudine; lopinavir plus ritonavir; nucleoside analog; remdesivir; sialidase inhibitor; tenofovir disoproxil; umifenovir; antivirus agent; antiviral therapy; Article; Chinese medicine; contact examination; coronavirus disease 2019; Middle East respiratory syndrome coronavirus; nonhuman; pandemic; pneumonia; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; Taiwan; upper respiratory tract infection; virus carrier; virus strain; virus transmission; animal; Betacoronavirus; communicable disease; Coronavirinae; Coronavirus infection; host range; human; pathogenicity; severe acute respiratory syndrome; veterinary medicine; virology; virus pneumonia; zoonosis; Animals; Antiviral Agents; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus; Coronavirus Infections; Host Specificity; Humans; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Zoonosesjournal article10.1016/j.jmii.2020.02.0012-s2.0-85078958617